Clinical Trial Update: A Study to Investigate Efficacy and Safety of SAR441566 in Patients With Ulcerative Colitis [Phase 2]

View source ↗

Summary

This update reports a Phase 2 clinical trial evaluating the efficacy and safety of SAR441566 in patients with Ulcerative colitis, currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ulcerative Colitis

Drugs mentioned

• SAR441566 (SAR441566)

Snippet

Sponsor: Sanofi | Conditions: Colitis Ulcerative | Phase 2 | Status: RECRUITING